Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966471370> ?p ?o ?g. }
- W1966471370 endingPage "18" @default.
- W1966471370 startingPage "1" @default.
- W1966471370 abstract "Some anticancer drugs, but not all, inhibit replication of human immunodeficiency virus (HIV) and thus, exhibit a therapeutic potential. Such drugs, unlike the traditional HIV enzyme inhibitors, could suppress HIV strains that are resistant to inhibitors of viral enzymes, decrease proviral burden in vivo, or reduce reservoirs of infection via killing infected cells. Thus, they may be an effective adjunct therapy or perhaps result in a cure. The incidence of HIV infection and AIDS mortalities continue to increase worldwide, including the United States and parts of Africa, with a parallel increase in a number of other manifestations, including AIDS defining malignancies. The basis for continual spread of HIV presumably in large part stems from the viral resistance to previously successful drugs and the lack of curative antiretroviral drugs. To reverse these trends, other approaches for AIDS therapy must be developed. One possibility is the development of potent anticancer drugs, that exhibit anti-HIV activities. At least four chemically and pharmacologically distinct classes of anticancer drugs, i.e. certain cyclin-dependent kinase inhibitors (CDKIs), topoisomerase 1 enzyme (top 1) inhibitors, non-nucleoside antimetabolites, and estrogen receptor ligands are promising candidates. These drugs, at high doses are used for cancer therapy; at lower concentrations they exhibit anti-HIV activities in cultured cells. While the antiretroviral and the anticancer activities of the cdk inhibitor flavopiridol appear to be mutually exclusive and unrelated in cells and animal model(s) of HIV disease, the top 1 inhibitor 9-nitrocamptothecin, as well as the cdk-inhibitor roscovitine inhibit replication of HIV via selective sensitization of HIV-infected cells to apoptosis. In contrast, the inhibitory effects of these compounds are different from other cancer therapeutics that, at toxic concentrations, activate HIV either in cultured cells (such as certain ingenol and butyrate derivatives) and/or in patients (such as the widely used cyclophosmamide and cisplatin). This quality may lead to the eradication of proviral reservoirs, which is not accomplished by the currently available antiretroviral drugs. In this review, relevant available clinical and in vitro data that either support or discourage using certain anticancer drugs for treatment of HIV disease, and the rationales for developing novel antiretroviral drugs that may target infected cells rather than viral proteins are discussed." @default.
- W1966471370 created "2016-06-24" @default.
- W1966471370 creator A5002139928 @default.
- W1966471370 creator A5040135024 @default.
- W1966471370 creator A5069070510 @default.
- W1966471370 date "2004-01-01" @default.
- W1966471370 modified "2023-10-17" @default.
- W1966471370 title "A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics" @default.
- W1966471370 cites W150926781 @default.
- W1966471370 cites W151873731 @default.
- W1966471370 cites W1520328387 @default.
- W1966471370 cites W1520782722 @default.
- W1966471370 cites W1542594185 @default.
- W1966471370 cites W1562467541 @default.
- W1966471370 cites W1573325703 @default.
- W1966471370 cites W1588657403 @default.
- W1966471370 cites W1590436404 @default.
- W1966471370 cites W1594148627 @default.
- W1966471370 cites W163451487 @default.
- W1966471370 cites W1798951145 @default.
- W1966471370 cites W1822517626 @default.
- W1966471370 cites W1875822544 @default.
- W1966471370 cites W1888982058 @default.
- W1966471370 cites W1931763360 @default.
- W1966471370 cites W1968865659 @default.
- W1966471370 cites W1968950430 @default.
- W1966471370 cites W1971263088 @default.
- W1966471370 cites W1972052443 @default.
- W1966471370 cites W1973069540 @default.
- W1966471370 cites W1977470105 @default.
- W1966471370 cites W1977638996 @default.
- W1966471370 cites W1977808770 @default.
- W1966471370 cites W1978044485 @default.
- W1966471370 cites W1979107592 @default.
- W1966471370 cites W1983274261 @default.
- W1966471370 cites W1983892160 @default.
- W1966471370 cites W1986010069 @default.
- W1966471370 cites W1989605545 @default.
- W1966471370 cites W1990628942 @default.
- W1966471370 cites W1993654534 @default.
- W1966471370 cites W1994966130 @default.
- W1966471370 cites W1996315910 @default.
- W1966471370 cites W2003655730 @default.
- W1966471370 cites W2005447219 @default.
- W1966471370 cites W2005767120 @default.
- W1966471370 cites W2006800136 @default.
- W1966471370 cites W2007724973 @default.
- W1966471370 cites W2010725017 @default.
- W1966471370 cites W2012976492 @default.
- W1966471370 cites W2013048947 @default.
- W1966471370 cites W2013920551 @default.
- W1966471370 cites W2014535598 @default.
- W1966471370 cites W2014789558 @default.
- W1966471370 cites W2015032724 @default.
- W1966471370 cites W2016843909 @default.
- W1966471370 cites W2017436619 @default.
- W1966471370 cites W2019503198 @default.
- W1966471370 cites W2021755065 @default.
- W1966471370 cites W2026016034 @default.
- W1966471370 cites W2027198209 @default.
- W1966471370 cites W2027956728 @default.
- W1966471370 cites W2029126048 @default.
- W1966471370 cites W2029228159 @default.
- W1966471370 cites W2029273457 @default.
- W1966471370 cites W2033017629 @default.
- W1966471370 cites W2033021499 @default.
- W1966471370 cites W2033580366 @default.
- W1966471370 cites W2036804890 @default.
- W1966471370 cites W2039030118 @default.
- W1966471370 cites W2039771541 @default.
- W1966471370 cites W2041695570 @default.
- W1966471370 cites W2041973943 @default.
- W1966471370 cites W2042727124 @default.
- W1966471370 cites W2043049357 @default.
- W1966471370 cites W2047026864 @default.
- W1966471370 cites W2048194864 @default.
- W1966471370 cites W2048690719 @default.
- W1966471370 cites W2048778747 @default.
- W1966471370 cites W2049394301 @default.
- W1966471370 cites W2050903066 @default.
- W1966471370 cites W2051477778 @default.
- W1966471370 cites W2051761798 @default.
- W1966471370 cites W2053699319 @default.
- W1966471370 cites W2055145160 @default.
- W1966471370 cites W2055898114 @default.
- W1966471370 cites W2055903147 @default.
- W1966471370 cites W2056114994 @default.
- W1966471370 cites W2056249358 @default.
- W1966471370 cites W2058563502 @default.
- W1966471370 cites W2059261803 @default.
- W1966471370 cites W2061483408 @default.
- W1966471370 cites W2061904336 @default.
- W1966471370 cites W2062228200 @default.
- W1966471370 cites W2064282640 @default.
- W1966471370 cites W2064859641 @default.
- W1966471370 cites W2065550112 @default.
- W1966471370 cites W2067024881 @default.
- W1966471370 cites W2069818112 @default.